MBX Biosciences, Inc. MBX Cash Flow Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| -$86.97M-40.5% | -$61.92M-90.2% | ||
| $337K+10.1% | $306K— | ||
| $8.68M+66.2% | $5.22M— | ||
| -$2.46M-163% | $3.93M+853% | ||
| $7.05M+109% | $3.37M+7,398% | ||
| $2.7M+14.9% | $2.35M— | ||
| —— | -$153K— | ||
| -$79.95M-46.2% | -$54.68M— | ||
| $1.93M+121% | $874K— | ||
| -$83.71M+47.9% | -$160.6M— | ||
| $2.42M+456% | $434K— | ||
| $189.59M-19.1% | $234.24M— | ||
| —— | —— | ||
| $3.61M+23.3% | $2.93M— | ||
| $337K+10.1% | $306K— | ||
| —— | -$153K— | ||
| —— | $0-100% | ||
| $2.7M+14.9% | $2.35M— | ||
| $133K+25.5% | $106K— | ||
| $771K-81.0% | $4.06M— | ||
| —— | $174.54M— | ||
| —— | —— | ||
| —— | —— | ||
| —— | -$153K— | ||
| —— | —— | ||
| -$81.88M-47.4% | -$55.56M— | ||
| -$81.88M-47.4% | -$55.56M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does MBX Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.